Data mining from cBioportal and Oncomine support overexpression of AMPKα1 and AMPKα2 in a group of neuroendocrine prostate carcinomas (Supplementary Figs S7, S8). The gene discussed is PRKAA2; the disease is prostate neuroendocrine neoplasm.